The Biochemical-Immunology Window:

A Molecular View of Psychiatric Case Management

Russell Jaffe, MD, Ph.D. and Oscar Rogers Kruesi, MD 

Molecular regulation of brain metabolism and function can now be measured selectively. Patients with mood and thought disorders can often be classified based on this information. Clinical management can often be improved by therapeutic interventions based on advanced chemical and immunologic testing techniques. The relevant information is distributed over various medical, laboratory, and research disciplines and, thus, not easily accessible by practicing psychiatrists. This article seeks to bridge this gap. This article focuses on a molecular and cell biology look at the diagnosis and clinical management of the depressions and the schizophrenias.  Read more